See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Celcuity Inc. Announces Pricing of Concurrent Public Offerings of 2.750% Convertible Senior ...

Summary by Hastings Tribune
MINNEAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the pricing of its underwritten public offering of $175,000,000 aggregate principal amount of its…

1 Articles

Hastings TribuneHastings Tribune
Center

Celcuity Inc. Announces Pricing of Concurrent Public Offerings of 2.750% Convertible Senior ...

MINNEAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the pricing of its underwritten public offering of $175,000,000 aggregate principal amount of its…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Hastings Tribune broke the news in on Wednesday, July 30, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Minneapolis, Minnesota icon

Minneapolis, Minnesota

News
For You
SearchBlindspotLocal